Affordable Access

Safety and efficacy of interferon retreatment in children with chronic hepatitis B.

Authors
Type
Published Article
Journal
European journal of pediatrics
Publication Date
Volume
157
Issue
5
Pages
382–385
Identifiers
PMID: 9625334
Source
Medline
License
Unknown

Abstract

A second cycle of alpha-interferon during the 3 years following the first treatment in nonresponding children with chronic hepatitis B can be safely performed but did not increase HBeAg/anti-HBe seroconversion compared with the spontaneous seroconversion rate of patients without retreatment.

Statistics

Seen <100 times